Literature DB >> 17715449

Leukocytosis as a predictor for progression to haemolytic uraemic syndrome in Escherichia coli O157:H7 infection.

M A Anjay1, P Anoop, A Britland.   

Abstract

Entities:  

Mesh：

Year:  2007        PMID： 17715449      PMCID： PMC2084030          DOI： 10.1136/adc.2007.120972

Source DB:  PubMed          Journal:  Arch Dis Child        ISSN： 0003-9888            Impact factor:   3.791


× No keyword cloud information.
  16 in total

1.  Guidelines for the control of infection with Vero cytotoxin producing Escherichia coli (VTEC). Subcommittee of the PHLS Advisory Committee on Gastrointestinal Infections.

Authors: 
Journal:  Commun Dis Public Health       Date:  2000-03

Review 2.  Potential therapeutic agents for the prevention and treatment of haemolytic uraemic syndrome in shiga toxin producing Escherichia coli infection.

Authors:  Alisdair A MacConnachie; W T Andrew Todd
Journal:  Curr Opin Infect Dis       Date:  2004-10       Impact factor: 4.915

Review 3.  The epidemiology of infections caused by Escherichia coli O157:H7, other enterohemorrhagic E. coli, and the associated hemolytic uremic syndrome.

Authors:  P M Griffin; R V Tauxe
Journal:  Epidemiol Rev       Date:  1991       Impact factor: 6.222

4.  Monitoring patients in the community with suspected Escherichia coli O157 infection during a large outbreak in Scotland in 1996.

Authors:  R Wood; M Donaghy; S Dundas
Journal:  Epidemiol Infect       Date:  2001-12       Impact factor: 2.451

5.  The central Scotland Escherichia coli O157:H7 outbreak: risk factors for the hemolytic uremic syndrome and death among hospitalized patients.

Authors:  S Dundas; W T Todd; A I Stewart; P S Murdoch; A K Chaudhuri; S J Hutchinson
Journal:  Clin Infect Dis       Date:  2001-09-05       Impact factor: 9.079

6.  Predictors for the development of haemolytic uraemic syndrome with Escherichia coli O157:H7 infections: with focus on the day of illness.

Authors:  K Ikeda; O Ida; K Kimoto; T Takatorige; N Nakanishi; K Tatara
Journal:  Epidemiol Infect       Date:  2000-06       Impact factor: 2.451

7.  Leukocytosis in children with Escherichia coli O157:H7 enteritis developing the hemolytic-uremic syndrome.

Authors:  C Buteau; F Proulx; M Chaibou; D Raymond; M J Clermont; M M Mariscalco; M H Lebel; E Seidman
Journal:  Pediatr Infect Dis J       Date:  2000-07       Impact factor: 2.129

8.  Hemolytic-uremic syndrome during an outbreak of Escherichia coli O157:H7 infections in institutions for mentally retarded persons: clinical and epidemiologic observations.

Authors:  A T Pavia; C R Nichols; D P Green; R V Tauxe; S Mottice; K D Greene; J G Wells; R L Siegler; E D Brewer; D Hannon
Journal:  J Pediatr       Date:  1990-04       Impact factor: 4.406

9.  Long term renal outcome of childhood haemolytic uraemic syndrome.

Authors:  M M Fitzpatrick; V Shah; R S Trompeter; M J Dillon; T M Barratt
Journal:  BMJ       Date:  1991-08-31

10.  Hemolytic uremic syndrome risk and Escherichia coli O157:H7.

Authors:  Boldtsetseg Tserenpuntsag; Hwa-Gan Chang; Perry F Smith; Dale L Morse
Journal:  Emerg Infect Dis       Date:  2005-12       Impact factor: 6.883
View more
  1 in total

1.  Severely ill pediatric patients with Shiga toxin-associated hemolytic uremic syndrome (STEC-HUS) who suffered from multiple organ involvement in the early stage.

Authors:  Mariana Luna; Mariana Kamariski; Iliana Principi; Victoria Bocanegra; Patricia G Vallés
Journal:  Pediatr Nephrol       Date:  2020-11-17       Impact factor: 3.714
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.